Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01508 CHINA RE
RTNominal down0.510 -0.010 (-1.923%)
Others

25/05/2018 11:50

[I-bank focus]C-ROSS phase II may tighten capital adequacy

[ET Net News Agency, 25 May 2018] The China Banking and Insurance Regulatory Commission
(CBIRC) published its roadmap and timetable for C-ROSS (China Risk Oriented Solvency
System) Phase II, targeting to complete 36 projects by the end of June 2020.
Nomura expects the amendments may further tighten capital adequacy under the ongoing
deleveraging process. Especially in terms of core capital of life insurers, the prudent
confirmation on residual margin of inforce policies would directly impact solvency ratio,
EV and NBV on life insurers.
The research house has already factored in the negative impact from the tightening of
regulations on capital requirements, by lowering reported EV by 5% and NBV by 8% in its
valuation models. (KL)

Remark: Real time quote last updated: 19/04/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.